Ladarixin

Published

dm+d

Unassigned

New Medicines

New onset type 1 diabetes mellitus

Information

New molecular entity
Dompe farmaceutici
Dompe farmaceutici

Development and Regulatory status

None
Phase III Clinical Trials
None

Category

CXCL-8 or Interleukin-8 (IL-8) inhibitor
Approximately 15% of those with diabetes have type 1 diabetes, an autoimmune disease caused by pancreatic beta cell destruction leadin to lifelong insulin dependence.[1],[2] Currently available treatment approaches focus on glycemic control and do not address the high unmet medical need of delaying disease progression by preserving β-cell function [1].
New onset type 1 diabetes mellitus
Oral